at pfizer, our culture values straight talk. i i actually have a coin, i won't bring it out today, it expresses that philosophy. so today i wanted to have a candid conversation with you about the risks of drug discovery and development, the economic contributions of our industry, the barriers to patient access to affordable health care including medicines and some observations regarding how we can create a health care system that supports innovation and provides patient access. drug discovery or and development. if you think back to what treatments were available in the 1940s -- i know most of us can't do that -- they were available for infections, depression, ulcers, blood pressure, parkinsons. there was almost nothing. you could look at a tv ad and see a patient in front of a doctor in black and white, and the medicine cabinet behind that physician, and he'd turn, and it was bare. today that is not the situation. today we have incredible medicines that have turned fatal illnesses like hiv and aids into chronic conditions. slow

i will share with you pfizer's example. our first in class drug for the treatment of breast cancer, one of the deadliest and poorly understood cancers. it started in 1990 with original research done by independent researchers that identified and characterized t regulated cell division. through researchers at ucla we identified the right patient population for our compound. by 2008 we had an acceptable molecule that we believe appropriately interfered with the disease to disrupt the growth of tumors. this result was that after 25 years of initial basic research, we had a cdk inhibitor. seven years after the first patient was dosed in clinical trials, it was approved by the fda. more than 50000 patients in the u.s. alone have been treated since its approval in 2015. before the drug was approved and launched, we began conversations with the healthcare community. we spoke to more than 80 payers, more than 20 breast cance cancer experts and oncologist to understand the value of this medicine. what it does, what it does against c

one of which was pfizer. to discover and develop new drugs, the biopharmaceutical industry spends six times more r&d compared to other major industries in the u.s. in 2015, the industry invested $50.8 billion for research and development. that is $28 billion more than the entire nih health budget. of which only a fraction is dedicated to drug discovery. the drug discovery process is complex and not well understood. after 38 years in the industry, it is one of the most complex undertakings that humanity has. to take an idea and shepherded through the drug discovery process, ensuring excellence at every stage and data at every stage to finally get a drug that can be taken by humans with a positive risk-benefit equation. let's briefly review what it takes to discover and bring new medicine to patients in layman's terms. the process begins with basic research done by researchers within academic institutions. these researchers find postulate -- find, postulate and get insights into a disease and approaches for tre

the cost of pfizer $40 million. year. i mean, in a 52 billion-dollar corporations, that's nothing because no one is using our medicines in exchanges because the exchanges don't provide them access. i think we do need to reform the health care the way it's delivered and the consequences will be with patients. >> a lot of people have the perception that the pharmaceutical industry is a very powerful industry. is it just a layman's thinking that you couldn't prevail upon the insurance industry? >> taking more revenues and paying out in premiums is what they do. true. [laughter] >> therefore there's no incentive. >> not a bit. >> well, moving on question from the audience. the american medical association, the american hospital association and the american association of clinical physicians, as well as other healthcare groups have expressed their opposition to the current republican affordable healthcare bill. does pfizer also oppose this bill. if so why, if not why not? we are in a democracy. everybody can express their own

pfizer rallied 10% last month alone. put it all together, and lang thinks this is a very, very pretty picture. it really is standard. it's got the w. it's got the bullish cross. strong rsi. i see why he says this is the best chart. next up, take a gander at merck's chart. a lot of people own merck. unlike the rest of the pharmaceutical space, merck had a great year in 2016. nice, huh? that rally has only continued in 2017. from fraser, good job. stock up 50% since the beginning of last year. lang know it's been rep lentless wrong on very strong buying. for charters, volume is like a lie detector. any move on strong volume is a move that's telling the truth. even better, the mac d indicator, it just made -- there we go again. the bullish crossover that was a few weeks ago. just this week, merck broke out above the long term ceiling that really kept it lower. it kept the lid on 64 bucks, making new all-time high lang likes this chart and thinks merck isn't finished going up, which to me makes a lot of sense because it's go

name like pfizer, ely lilly, and johnson and johnson. why aren't we seeing more resnacks. >> when you look at it. we are seeing reaction. it started january 31st after the executives sat down with trump. the knee jerk initially was you can't be involved in these stocks. after the meeting, they said we'll limit the pricing going forward. that seemed to give a calmness to the marketplace. you look at merck sense january 31st. pfizer. and then throw in the biotech names. you see the same story playing out. continuing year to date numbers. it is really the january 31st to date numbers. i think it is negotiation and they're will to work the president. >> it's interesting. across the board they were trading higher. the ones that get dinged whenever you talk about negotiating prices or repeal and replace. >>er i think to pete's opponent, you've had these drug ceos in the oval office. i think it was a lot more rhetoric than real bite to what he was saying. i think he had to say to it rally his base or to give them something. >> it sounds like th

there is zero evidence. >> we would not know it because pfizer cortisol classified in secret. let's change the subject and talk about jeff sessions. should should he have recused himself? >> yes. the reason be and sometimes the allegation is more damaging than the actual crime that is alleged. certainly he did not purge himself. i listen to the question and answer, he is now submitting supplemental affidavit to the committee. >> should he recuse himself neil? >> of course. he should've resigned. >> should've loretta lynch recused him self when she met with a woman who is under criminal investigation and never told the dam soul? >> i don't know what one has to do with the other. >> jeff sessions lied under oath or. >> he did not lie under oath. >> he lied under oath. then when he resubmitted the testimony he said the same thing. listen -- >> so was that alive when she said she didn't sit. >> she wasn't under oath. >> so you can my to the american public. >> there's a difference. >> next, a former campaign spokesperson joins us live. don't go away gel insoles have ae gel wave de

pfizer has 181. there booked over twitter me a dollars of short -- booked over $200 billion offshore. it seems, aren't these bit former companies able to take advantage of the research and development tax credit were taxpayers are justifiably not portioned a significant of the r&d expenses? >> i am sorry. i do not catch all of your question. >> we have a host of legal ways for big pharma to dodge taxes and at the same time that air price gouge's people all over this country. pharmaceuticals that just about any other country in the world. it does not relate to this tax break and there is not a penny that a medicare recipient is going to get out of this provision. only a $25 billion right back to the hands of big pharma. this provision resulted, did it not, from negotiations before the affordable care act to begin the legislative process in congress between the obama administration and the pharmaceutical industry in lieu the form industry doing something significant like breaking the medicare price neg

you have to get a pfizer court order for americans anywhere in the world. host: you served as a staffer on the house intelligence committee. when devin nunes travel to the white house, he might have had some of his associates tapped into a condition as part of a wider search of data, was that appropriate? had --if chairman inez toes have access intelligence information, the white house probably have access to the same information. what is interesting is the question of what he was talking about. we may never know because actual intelligence information probably will not be revealed to the public. he talked about this being incidentally collected information. americans, some of president trump's associates were overheard medicating with foreigners. that is not as surprising as you might think. the president and his senior officials, people associated with the campaign, it would not be surprising if they are talking to foreigners once the election is over and they took office. it is not surprising that people were seductively collected. the question is whethe

pfizer drug gets you done. >> they can sense it. the international man of mystery is out with a warning. and a call to action. he will explain. you're watching "fast money." >>> that is what happened to biotech today. but there is a key event tomorrow that could soon turn it around. we'll tell you what that is. plus guy a dodami is unstoppabl taking three straight matches in the "fast money" madness tournament. but now he faces his toughest challenge yet. we'll tell you what it is when "fast money" returns. fees? what did you have in mind? i don't know. $4.95 per trade? uhhh. and i was wondering if your brokerage offers some sort of guarantee? guarantee? where we can get our fees and commissions back if we're not happy. so can you offer me what schwab is offering? what's with all the questions? ask your broker if they're offering $4.95 online equity trades and a satisfaction guarantee. if you don't like their answer, ask again at schwab. various: (shouting) heigh! ho! ( ♪ ) it's off to work we go! woman: on the gulf coast, new exxon

the faster that we can put any pfizer problems did that come in the best for the american people -- >> and i would join the chairman in what he said earlier that i would expect the fbi and the department of fully cooperate if they do not --. if they do not, [indiscernible] >> [inaudible] hold on a second. let's go over here and then we will come back. [inaudible] yeah, i don't see this -- i don't see that there's one important question to it i think they are all important overall. this is great for, for the work that we have done over many years here on this committee because finally the american people are awakening to the fact creatingimir putin is problems for us and our allies all over the globe so this is something that i desperately wanted people to pay attention the lasts if administration paid closer attention to what we were saying at the time, the opportunities and the options that congress gave to the last administration to help the ukrainians and other countries, if they would have tillthose and not weighted the end unto after the election to do something i think would hav

announcer: pfizer ceo ian reid. >> no one is using our medicines in the exchanges, because the exchanges don't provide them access. i think we do need to reform the health care, the way it is delivered, and the consequences will be with patients. announcer: and scott pruitt on environmental policy. >> there are exciting things going on with technology across the globe. there are exciting things going on, but not here. most of it is happening in europe, presently, because of the disincentives we have put into play with respect to nuclear. if you care about these environmental concerns, nuclear ought to be in the mix. announcer: c-span programs are available at c-span.org, on our homepage, and by searching the video library. announcer: congressman dwight evans recently sat down with c-span for a profile interview. representative evans represents pennsylvania's second district. host: congressman, democratic pennsylvania, you have been serving in public office since 1980. >> correct. host: what have you been doing over the years? >> i was in the state legislature in pennsylvania. i was chair

he could know whether or not there was a pfizer warrant. how true is that?ry likely true. it could be that there's an investigation that the intelligence community and law enforcement agencies don't want to reveal but what is concerning is the president is taking action based on information from far right media outlets that is concerning. donald trump has access to more information than anyone else in the world he is receiving information and then taking action upon information that is coming from these less than credible, to put it nicely, sources. so that's what is really concerning here and a agree that we need a more serious investigation. a lot of people say one thing or another and we need a special select committee that's bipartisan. i don't think the house is credible right now on this to investigate and we also need a special council in the doj. both of these served different purposes and do different things. we need them both. it's very critical. >> david, . >>> president trump is set to unveil his new travel ban as soon as today. what's in it? has

ian read: pfizer ceo on pharmaceutical cost. >> we do need to reform the health care, the way it is delivered and the consequences will be re-patients. and scott pruitt on environmental policy. >> there are some exciting things going on with respect to clean coal technology and in the nuclear space. most of that is happening in europe because of the disincentives we put into place in this country with respect to nuclear. if you hear about these environmental concerns, nuclear should be in the next. these are available at c-span.org y

. >> pfizer ceo ian read on pharmaceutical costs. >> no one's using our medicines in the exchanges because the exchanges don't provide them access. so i think we do need to reform the health care the way it's delivered and the consequences will be with patients. >> and epa administrator scott pruitt on environmental policy. >> there are some exciting things going on with respect to clean coal technology across the globe. there's some exciting things going on in the nuclear space but not here. most of that's happening in europe presently because of the disincentives that we put into play here in this country with respect to nuclear. i mean, if you really care about some of seize environmental concerns, nuclear ought to be in the mix. >> c-span.org and search the video library. >> congressman dwight evans recently sat down with c-span for a profile interview. he represents pennsylvania's 2nd district. >> congressman dwight evans, democrat of pennsylvania, you've been serving in public office since 1980. >> correct. >> what were you doing? what have you been doing over the years? >> i was in

. >> i just wanted to know what is going on with pfizer pharmaceutica pharmaceuticals. >> pfizer's sitting there, their need to make a deal and that would make everything work out. >> boo-yah, jim, from northern california. >> in regards to irk cconic, i received one from the elliott group which wants to replace the whole board. and so i would like to know your opinion. >> we're telling club members at action alerts.com that as we get close to it we will make a decision. we do like the fact that kleinfeld split the company up and created a lot of value, though. let's go to adam in texas. >> intrexon. >> when you biuy the tech stock, it's either going to go 50 or it's going to go 9. if you're in it, stick with it. let's to roy in california. >> boo-yah, jim. >> boo-yah, roy. >> i own raytheon stock. and that's it for the lightning round. >>> these daysive we're going to go out to dinner, if we're going to leave our precious restoration houses, we're -- it better be for a bargain or a great experience. nothing else will get us out the door. darden, the parent of olive garden is a bargain. ho

. >> pfizer ceo ian reid. the changes don't provide them access. i think we do need to reform the health care, the way it is delivered, and the consequences will be with patients. >> there are exciting things going on with technology going on across the globe, but not here. most of that is happening in europe because of the disincentives that we put into play in this country. if you care about some of these environmental concerns, you can go with a mix. >> these are available at www.c-span.org and by searching the video library. yesterday, the house voted to rule that would have prohibited the selling of customers private information by internet service providers. that regulation had not yet gone into effect. here is house debate on the bill. it is an hour and 15 minutes. mrs. blackburn: i do rise today in support of senate

. >> pfizer c.e.o. ian reed on pharmaceutical costs. >> no no one's using our medicines in the exchanges because the exchanges don't provide them access. so i think we do need to reform the health care the way it's delivered. and the consequences will be with patients. >> and e.p.a. administrator, scott pruitt, on environmental policy. >> there's some exciting things going on with respect to clean coal technology across the globe. there's exciting things going on in the nuclear space. but not here. most of that's happening in europe presently because of the disincentives that we put into play here in this country with respect to nuclear. if you really care about some of these environmental concerns, nuclear ought to be in the mix. >> c-span programs are available at cspan.org. on our home page and by searching the video library. >>'s spokesman sean spicer answered questions about the house intelligence committee's investigation of alleged wiretapping of the trump campaign a r

you didn't have anybody in your reporting say that was a pfizer warrant so that still doesn't explain why he would be so curious to think president obama is coming after him. >> sure. we're looking to find any information to say maybe this server was tapped. all we know that is the counter intelligence team at the fbi slook at this issue. that's it. >> david gregory, your thoughts? >> you know, what you have here is a lot of clues that point to something and we're not sure what it was. the idea that there's contact between trump officials and the russian government at a time when russia is up to no good and trying to manipulate the u.s. election. we have no evidence of collusion of anything done wrong in terms of the contact that will still be very piece mill and more mystery and we have solid clues to point to anything that would suggest that any trump official or the trump campaign was absolutely colluded with russia to manipulate tuchlt s. election. >> let's get a frame of reference for timing. timing is indicative with the fbi about how seriously they take something. never tell yo

the large drug makers coming you like to and pfizer moving less that eli lilly and pfizer moving less. i wanted to look at valuations within the health care group broadly. this includes subgroups we were just looking at. the price to earnings ratio of the s&p health care index versus the price earnings ratio of the s&p 500. on the bottom, the spread between them. this shows us that for the past several years, health care had been trading at a premium to the overall market. however, at the end of 2016 and into this year, now trading at a discount. something to keep in mind as we parse out and look over these health care headlines. vonnie: it is and will be for some time, thank you. let's get the bloomberg first word news. >> immigration advocates are planning legal challenges to the president revised travel ban. the new measure seen as less restrictive but a lawyer for the american civil liberties union says the executive order is still a ban on muslims. i rock has been dropped -- iraq has been dropped from the list of citizens whose -- whose citizens are barred from entering the u.s.

over the years, like companies like pfizer, employed millions of immigrants and brooklyn neighborhoods and businesses grew to accommodate them but the gulf of history is fixle and brooklyn's fortunes shift in the second half of the 20th 20th century. the factories that sustained so many americans started to leave, not for china and mexico, as in the case today, but for far less crowded and more truck-friendly american suburbs and ex-u-s. in 1956 when the dodger owner broke the heart of every red-blooded brooklynites dodgers to los angeles. by the 1960s the waterfront was becoming a sad, empty using shell of it former self. in 1966 the navy yard, which had during world war ii the largest and best known employer, was decommissioned. by the time i moved to park slope, about a mile away from the navy yard, it was home to a few operate can warehouses but mostly acres acres acres of emp, ferrell dog and the occasionol body reportedly dumped by one of brooklyn's legendary wise guys. there were still plenty of holdovers at the time we moved in. our next door nab were an elderly irish couple wh

remarks now from the head of pfizer on healthcare and the cost of prescription drugs from the national press club.

and proving corporate issues that having hostage's by politics, we have coca-cola and pfizer try the of about 14 billion euros. to talk europe and all things credit i want to bring in our roundtable. what do you make of a credit market, sovereign debt market held hostage by a single election. >> the european market is held hostage by a number of things. the ecb owns 10% of the european corporate bond market. roughly 100 of them are negative securities. it is going to be evaluated in the context of the sovereign risk. it is a precarious opposition because you are dealing with the end of the purchase program. the probability of her winning cannot be completely dismissed. victories are somewhat not clear. let's look at the situation in europe. i wonder what takes is higher. fundamentally you need growth, you need reforms. is that going to happen anytime soon? >> i think it is not a fundamental issue in the , which is that if you it through these elections think the focus starts to turn again on ecb exit and what that means. you had the same cyclical upturn in growth. it seems like it is

general electric, pfizer, vf court and vodafone. >> all right. wow, interesting selection here.o. i just love portfolios that have above average yield. pfizer, drug company, higher yield, ge, industrial higher yield, duke energy, one of our absolute favorite yields. i like con ed, but we'll go with duke. vf, higher-year old and vodafone. a utility, industrial and drug company. what can i say, other than -- >> hallelujah! will your business be ready when growth presents itself? american express open cards can help you take on a new job, or fill a big order or expand your office and take on whatever comes next. find out how american express cards and services can help prepare you for growth at open.com. find out how american express cards and services a winter weather emergency... governor has declared announcer: soon, insurance companies won't pay for damages, that is, not if they can help prevent damages from happening in the first place. at cognizant, we're turning the industry known for processing claims, into one focused on prevention with predictive analytics... helping them

so it's not a surprise to see pfizer, merck, and j and j to be having weakness.they're not from a galaxy far, far away, but they may be just as dangerous to american workers. as dangerous as any star trooper in the galactic empire. robotic waiters are already being rolled out. we're going to tell you where. even worse, the man who warned of this very possibility. billionaire jeff green now says the economic collapse sparked by robots is coming sooner to the u.s. than you think. what you and the country must do about it. he's going to tell you next. why pause a spontaneous moment? cialis for daily use treats ed and the urinary symptoms of bph. tell your doctor about your medicines, and ask if your heart is healthy enough for sex. do not take cialis if you take nitrates for chest pain, or adempas® for pulmonary hypertension, as this may cause an unsafe drop in blood pressure. do not drink alcohol in excess. to avoid long-term injury, get medical help right away for an erection lasting more than four hours. if you have a sudden decrease or loss of hearing or vision,

allergan and pfizer. is always a bull market somewhere and i promise to find it for you on "mad money." i'm jim cramer and i'll see you tomorrow. >> welcome to the shark tank, where entrepreneurs seeking an investment will face these sharks. if they hear a great idea, they'll invest their own money or fight each other for a deal. this is "shark tank." ♪ (ship horn blows) i'm jim tselikis... and i'm sabin lomac. and we are cousins from portland, maine. and together, we are cousins maine lobster. best part about growing up in maine is the family, being by the water, but most importantly, the lobster. maine lobster is the most tender, succulent meat you'll ever have. we are from maine but currently living in los angeles. who wants some fresh maine lobster?!

you will find that president obama in 2012 when he cannot get a pfizer court to give him the right to intercept certain or -- past surveillance of certain things, he signed what is called presidential policy 20. that gives him, the presidential policy 20, it gives them the right to survey all, to do orveillance, wiretapping whatever. i do believe he did that. host: are you referring to president trump's charges about what happened at trump tower during the election? believe it happened. i believe everybody as far as wikileaks should read this book because they will find out how wikileaks is getting most of this stuff. from the other story front page of the business section of "usa today." the story noting that trove threatens to reprise the distrust when snowden revealed nsa collaboration between the government and internet companies in used by millions. tech companies have been trying to repair the brand damage since. they note silicon valley has responded to this latest document dump with silence. i want to hear from you. your thoughts. your trust of tech companies and the issue of

question, it has been reported in the media, there was pfizer --ication, fisa application denied earlier in the year and later in the ear, a second fisa application was granted. i'm wondering what if, that has een reported, but there has been no proof shown to the american people. curious, what if james clapper went on meet the and said no ay there was no wiretapping, any of his him or knowledge, but i'm wondering, was a fisa e never application made in october, what if the wiretapping was done those are my two questions. host: thanks, caller. first with regard to the question, the purchase of health lines, e across state this has been a long-standing lank of the republicans .eplacement plan i want to emphasize the plan was released just yesterday, it is pages long, vinot had a chance to read it, i would be surprised if it did not include provision allowing for the purchase of health insurance lines because that has been part of the republican years.oposal for with regard to your second get to the need to bottom of this. swirling allegations around, based on unconfirmd and media reports.

pfizer trades at just 13 times earnings. allergan trades at 15 times earnings. i own that one for the charitable trust. you can follow along which joining the actionalertsplus.com club. i like lilly, but i keep waiting for it to come down. it's had such a big run in the last three months. a lot of it by the way is because of diabetes. i prefer you waited for a pullback before pulling the trigger. so here's the bottom line. treating diabetes is going to be a huge story for years to come, which is why i want to give you multiple ways to play it. dexcom and insulet both have exciting technology, although i prefer dexcom here. eli lilly has the best diabetes franchise of all the big pharma names. it's certainly the most stable way to invest in this terrible but definitely long-lasting trend. much more "mad money" ahead. what do allergan, jpmorgan, and wynn resorts all have in common? i'll reveal it and tell you how it could help you make money. then it's a texas bank that survived all the downturns in the energy sector. how did colin frost do it? i'm going to sit do

last year the us sold $49 billion worth of goods to germany — everything from boeing airliners to pfizerou look at this one $114 billion was the value of goods germany sold to the us. that's a lot of bmws — not to mention everything from industrial machinery to medicines. it's more than double. and it puts the difference — known as america's trade deficit with germany — at $65 billion. that's a bigger deficit than the us has with mexico — injanuary one of president trump's top trade advisors accused germany of using a "grossly undervalued" euro to "exploit" the us. chancellor merkel rejects the claim — and points out the thousands ofjobs created by german investment in the us. she says she will remind the president that bmw's us plant ,.:.s.:...=. £1: the bosses of bmw and another huge employer in the us — industrial giant siemens — will be travelling with her to make the point. we'll be getting the views of a frankfurt—based economist in 20 minutes' time. or like me you started work at three in the morning — this may wake you up. according to research by the rand corporation — lack of s

it is partnering up with pfizer., and they've got this javelin program underway to see whether or not the science could the used to treat other forms of cancer as well. if this works, maybe some of those other therapies work as well. matt: trade gate is calling the shares up 3% at the open. definitely a stock to watch. coming up, the market open. futures are unchanged. this is bloomberg. ♪ guy: it's friday. the market is about to open. this is bloomberg. we think it is likely to be a fairly flat story. we will see what happens on capitol hill later on, trying to get a sense of where this vote goes. apparently too close to call. at the moment, no real clear sense of directions. pointing to a mixed story. the cac down, london just a bit positive. interesting to look at the euro right now. we have european leaders meeting in rome to celebrate the 60th anniversary of the signing of the rome treaty. here you see your trading at 1.07. it has been around 1.08. it is only down 2% versus the dollar from november 8 when donald

look into it anyway because clearly when you take in its totality all of the leaks, whether or not pfizer was implemented correctly, you all know because you have all been asking these questions for many weeks now. many of the people mentioned, we have to know if those investigations are occurring. >> have you been in touch with the white house. [inaudible] that was a public statement that was sent over the weekend. >> as you all know, the way this works, if someone is going to be put under investigation, it's not the way that it would go. now, is it possible president obama knew about general flynn, we don't know the answer to that question. is it possible president obama was directing his department of justice to go into the court to seek a warrant? i don't know. >> the president made a declarative statement and now your committee is using it to investigate this. is that a proper thing for the to do? he made a declarative statement. as you all know, the president is new to politics pretty's been been doing this a little over year. i think a lot of the things he said, you guys sometimes

sean duffy is here and former ceo at pfizer hank mcconnell joining us as well as chris raines. you have a big show this friday morning and we pick it up with snap inc. soaring on its first day of trading, the closing price 44% above, $17 offering price set on wednesday night, the day was valued at $40 billion, quite a day for snapchat. what do you think of this valuation? >> it is a payoff valuation trading at 60 times revenue. facebook, 14 times revenue, netflix at 7, alphabet at 6. you are paying big time for users that snap. the question is will they grow into the valuation. the problem is in the fourth quarter their growth slowed significantly to 3% and the reason is facebook introduced the instagram stories feature which is what snap does. a lot will happen this year to prove whether snap is a fad or they will be the people who capitalize on this space. an open question. maria: are there barriers to entry on this company? you said facebook is on the same thing. that is the question. is this so different there's a barrier to entry or not? >> barriers to entry are low and th

. >> pfizer ceo ian reed on pharmaceutical costs. >> no one is using our medicines in the exchanges because the exchanges don't provide them access. we need to reform health care the way it is delivered and the consequences will be for patients >> and epa administrator scott pruit: >> there is exciting things going on across the globe but not here. most of it is happening in europe because of indisincentives we put into play in this country. if you really care about some of these environmental concerns, we ought to be in the mix. >> they are available on our home page and by searching the video library. >> next, food and agricultural experts discuss genetically modified organisms known as gmos and their affect on the environment and food industry. this is just over an hour. [applause] >> thank you.

and proving corporate issues are held hostage somewhat by politics, we have coca-cola and pfizer drivingnce about 14 billion euros. to talk europe and all things credit, i want to bring back in our roundtable. tcw's ted rivelle, blackrock's jeff cucunato, and jpmorgan's oksana aronov. what do you make of a credit market, sovereign debt market held hostage by a single election in france? oksana: the european market is held hostage by a number of things, including the political picture. the ecb owns 10% of the european corporate bond market. that is roughly 800 securities, and roughly 100 of them are negative yielding securities. so as the bond market nears the end of the corporate support, every one of those issues will be evaluated on risk, the sovereign risk. the fundamentals are probably being overlooked by now. in that perspective, they are in proposition because you are dealing with the end of the purchase program. you are dealing with political risks that are frankly hard to know. marine le pen, as much as much as her numbers have calmed down, i think the probability of her winning

we know it has been reported that the obama administration applied for a pfizer warned sometime in june. that is been reported at least into outlets. then it was reported again in october that they apply for a warrant and receive that. hillary clinton had a tweet out on october 31 that the computer specialist identified communications between the trump campaign and the russians. we are adding all this up. we are not operating with a lot of facts. we don't know whether there was a warrant requested and approved or denied. some members of barack obama's intelligence committee say that is not the case. if this surveillance is taking place and there was no warrant, that doesn't preclude there is a rogue operator out there. that is at least as valid as the other theories. host: do you think president trump was adding that into the mix or gu think he has evidence? guest: i think he has evidence. no one has more access to intelligence and the president of united dates. -- united states. the chairman of the select committee on intel will be included in this and is doing an investigation this mo

host: what are the pfizer rules and how do they work -- fisa rules and how do they work?as the president wiretapped? what does that mean? we will get an explanation. we will turn to america's prison policy, why so many are being incarcerated and what needs to be done. we are moving ahead to the next hour of c-span's "washington journal." we are back in a minute. ♪ >> monday night on the communicators, we visit the state of the net conference and speak with the senior advisor to the house majority leader kevin mccarthy. we speak about how congress and companies are addressing policy and cyber security. >> the disruption by technology are so disruptive to our entire economy that government has no choice but to reflect that reality. we have been through this. i don't think we have ever been through this at quite this sale. -- scale. created incy was an agrarian society and has survived and thrived. we are at that same inflection point today between an industrial economy and an information economy. that creates an amazing opportunity not just to survive as a democracy but to

. >> pfizer ceo ian reese on pharmaceutical talk. >> no one's using medicated medicaid in the expansion to provide access so i think we do need to reform the health care and the consequences will be patient. >> and epa administrator scott pruitt on environmental policy. >> there's things going on with respect to clean coal

or were not listening to the nice its citizens on domestic soil which is a crime unless you have a pfizer warrant. either you are or you aren't pregnant. >> this is insane. do they have them listening to the next president and the south of his united states. that's a real problem. everybody should be concerned about it. when the irs incidentally targeted conservative tea party groups and have their paperwork held up for two years. it was just an accident. incidental. nothing is on purpose anymore. there's nothing to see move away. this is insane. can you imagine if this was hillary clinton and she incidentally picked up. after her election loss. this is crazy. and director comey never even indicted hillary because she didn't intentionally commit the felony. the whole thing boils down to reading someone else's mind. it brings me to director comey. he answered in a fishy way about whether or not the tapping took place he answered specifically whether president obama ordered it and then suggested that he may not even be cooperating with the house intelligence committee investigation into thi

. >> pfizer ceo ian read on for suitable costs. using her medicine on the exchanges because the exchanges don't provide them access. we do need to reform the health care the way it is delivered and the consequences will be motivations. >> scott pruitt on environmental policy. >> there are exciting things going on with clean coal technology. there are things going on in the nuclear space. not here. most of that is in europe because of the disincentives we put into play here. if you care about some of these environmental concerns, nuclear ought to be in the mix. >> c-span progress are available at c-span.org on our homepage and by searching the video library. pound [gavel pound] >> subcommittee will come to order. without objection, the chair is authorized to declare recesses of the committee at any time. we welcome everyone to today's hearing on restoring enforcement of our nation's immigration laws. the chair recognizes himself for an opening statement. it is fitting that the title of this meeting is restoring our

so companies like pfizer with only two wondered billions of profits with 181 subsidiaries to avoid taxes. are there any tax breaks this provision in the community pharmacies on the west side of san antonio or any other pharmacies around the country quite. >> i am not clear on your question. this special tax provision that the republicans have provided, a $25 billion for big forma but there isn't any for any community pharmacy. >> as i was explaining, this is like an excise tax on the manufacturers it does not the apply to retail sales. >> might experience with community pharmacies they don't have one subsidiary to dodge taxes but pfizer has 181. they have booked over $200 billion offshore profits. it just seems to me that they are also able to take advantage of the research and development tax credit where taxpayers are not subsidized a significant portion of their expenses. don't they? been a times rea. i did not catch all of your question. >> we have a host of legal ways for big four months to dodge taxes at the same time reprise gouges all over the country. we pay more for pharmaceuti

. >> pfizer ceo ian read on pharmaceutical costs. >> no one's using our medicines in the exchanges becausehanges don't provide them access. so i think we do need to reform the health care the way it's delivered and the consequences will be with patients. >> and epa administrator scott pruitt on environmental policy. >> there are some exciting things going on with respect to clean coal technology across the globe. there's some exciting things going on in the nuclear space but not here. most of that's happening in europe presently because of the disincentives that we put into play here in this country with respect to nuclear. i mean, if you really care about some of seize environmental concerns, nuclear ought to be in the mix

. >> pfizer c.e.o. ian reed on pharmaceutical costs. >> no one is using our medicines in the exchanges because the exchanges don't provide them access so i do think we need to reform the health care the way it's delivered and the consequences will be with patient. >> and e.p.a. administrator scott pruitt on environmental policy. administrator pruitt: there are some exciting things going on with respect to clean coal technology across the globe. there are exciting things going on in the nuclear space but not here. it's happening in europe because of the disincentives we put into play with regard to nuclear. nuclear ought to be in the mix. >> c-span programs are available at c-span.org, on our home page and by searching the video library. >> the u.s. house returns at 2:00 p.m. eastern for general speeches and then return at 5:00 dealing with emergency preparedness. the house will vote on those bills at 6:3ea

. >> pfizer ceo ian read on pharmaceutical costs. >> no one is using our medicines in the exchanges. do need to reform the health care the way it is delivered and the consequences will be -- >> and epa administrator scott pruitt on environmental policy. >> there are exciting things going on with clean coal technology and in the nuclear space but not here. most of that is happening in europe because of the disincentives we put into play here with respect to nuclear. if you care about environmental concerns, nuclear ought to be in the mix. >>> coming up in the morning, health and human services secretary tom price will testify about the white house's 2018 budget request for his department. we'll take you to a house appropriations subcommittee right here on c-span3. later military officials will brief lawmakers on the shortage of pilots in the military. that's live from a house armed services